Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Leucine

Research Leaders

7 sponsors active, led by University of Illinois at Urbana-Champaign

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Unknown3
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Leucine1
  • Manual Toothbrush And Powered Toothbrush1
  • Force Efforts With Haptic Feedback In Virtual Reality1

Active Sponsors

  • University of Illinois at Urbana-Champaign1
  • University of Illinois College of Medicine at Peoria1
  • Acıbadem Atunizade Hospital1
  • OSF Healthcare System1
  • Dow University of Health Sciences1

Top Investigators

Related Conditions

  • Cerebral Palsy Ataxic1
  • Cerebral Palsy1
  • Secondary Dystonia1
  • Cerebral Palsy Spastic1

Activity Timeline